Christopher P. Horan's most recent trade in Artiva Biotherapeutics Inc was a trade of 10,340 shares done at an average price of $6.8 . Disclosure was reported to the exchange on Oct. 5, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Artiva Biotherapeutics Inc | Mr. Christopher P. Horan | Chief Tech Operations Officer | Sale of securities on an exchange or to another person at price $ 6.84 per share. | 05 Oct 2026 | 10,340 | 312,744 | - | 6.8 | 70,697 | - |
| Artiva Biotherapeutics Inc | Mr. Christopher P. Horan | Chief Tech Operations Officer | 09 Sep 2026 | 120,000 | 120,000 | - | - | Employee Stock Option (Right to Buy) | ||
| Artiva Biotherapeutics Inc | Mr. Christopher P. Horan | Chief Tech Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 40,000 | 323,084 | - | 0 | Common Stock | |
| Artiva Biotherapeutics Inc | Mr. Christopher P. Horan | Chief Tech Operations Officer | Sale of securities on an exchange or to another person at price $ 11.16 per share. | 03 Sep 2026 | 10,366 | 283,084 | - | 11.2 | 115,638 | Common Stock |
| Artiva Biotherapeutics Inc | Mr. Christopher P. Horan | Chief Tech Operations Officer | Sale of securities on an exchange or to another person at price $ 9.01 per share. | 19 May 2026 | 7,002 | 293,450 | - | 9.0 | 63,073 | Common Stock |
| Artiva Biotherapeutics Inc | Mr. Christopher P. Horan | Chief Tech Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2026 | 117,300 | 302,639 | - | 0 | Common Stock | |
| Artiva Biotherapeutics Inc | Mr. Christopher P. Horan | Chief Tech Operations Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.00 per share. | 15 Feb 2026 | 2,187 | 300,452 | - | 4 | 8,748 | Common Stock |